Xiangyan Qiu
- Immunology top 10%
- Immune Cell Function and Interaction 2
- Immunotherapy and Immune Responses 2
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers 3
- CAR-T cell therapy research 2
-
- Viral gastroenteritis research and epidemiology 1
- SARS-CoV-2 and COVID-19 Research 1
-
- Advanced Image and Video Retrieval Techniques 1
-
- Photonic and Optical Devices 1
- Cited by
- ImmunologyOncologyBiotechnology
- Partner nations
- ChinaUnited StatesPhilippines
In The Last Decade
Xiangyan Qiu
6 papers receiving 450 citations
Hit Papers
Peers
Comparison fields: 5 of 56
- Immunology 345
- Oncology 298
- Biotechnology 14
- Cancer Research 23
- Pulmonary and Respiratory Medicine 41
Countries citing papers authored by Xiangyan Qiu
This map shows the geographic impact of Xiangyan Qiu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiangyan Qiu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiangyan Qiu more than expected).
Fields of papers citing papers by Xiangyan Qiu
This network shows the impact of papers produced by Xiangyan Qiu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiangyan Qiu. The network helps show where Xiangyan Qiu may publish in the future.
Co-authorship network
The 22 scholars most cited alongside Xiangyan Qiu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | PD-L1 on dendritic cells attenuates T cell activation and regulates response to immune checkpoint blockadebreakdown → | 2020 | 370 |
| 3 | 2020 | 1 | |
| 4 | 2018 | 69 | |
| 5 | 2018 | 11 | |
| 6 | 2008 | 1 |
About Xiangyan Qiu
Xiangyan Qiu is a scholar working on Immunology, Oncology and Infectious Diseases, having authored 6 papers that have together received 453 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (3 papers), CAR-T cell therapy research (2 papers), Immune Cell Function and Interaction (2 papers), Immunotherapy and Immune Responses (2 papers), Viral gastroenteritis research and epidemiology (1 paper), SARS-CoV-2 and COVID-19 Research (1 paper), Advanced Image and Video Retrieval Techniques (1 paper) and Photonic and Optical Devices (1 paper). The work is most often cited by research in Immunology (345 citations), Oncology (298 citations) and Biotechnology (14 citations). Xiangyan Qiu has collaborated with scholars based in China, United States and Philippines. Frequent co-authors include Haidong Tang, Hua Peng, Yong Liang, Jingya Guo, Yang‐Xin Fu, Peng Qi, Zihan Zhang, Mingyi Chen, Silin Zhang and Yuanyuan Zhang.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.